Last $3.40 USD
Change Today -0.13 / -3.68%
Volume 1.4M
PGNX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 04/15/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Charles A. Baker J.D.

Director and Member of Audit Committee, Regeneron Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 2 different industries.

See Board Relationships
80$515,425

Background*

Mr. Charles A. Baker, also known as Chuck, JD serves as a Business Advisor to biotechnology companies. Mr. Baker served as the Chief Executive Officer, President and Chairman of The Liposome Company, Inc., a biotechnology company developing and commercializing proprietary lipid- and liposome-based pharmaceuticals, from December 1989 to September 2000. Mr. Baker served in a senior management capacity in various companies, including tenures as Group Vice President of Squibb ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-789-2800
Fax: 914-789-2817

Board Members Memberships*

Former Chairman of the Board, Chief Executive Officer and President
1989-Present
Director and Member of Audit Committee
1994-2013
Former Independent Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee
2001-N/A
Former Director

Education*

JD
Columbia University
Bachelor's Degree
Swarthmore College
BA
Swarthmore College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$75,000
Total Calculated Compensation$515,425
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGNX:US $3.40 USD -0.13

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jean-Jacques Bienaimé Chief Executive Officer and Director
BioMarin Pharmaceutical Inc.
$821.1K
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
David E. I. Pyott Chairman and Chief Executive Officer
Allergan Inc.
$1.4M
Leonard Bell M.D.Co-Founder, Chief Executive Officer, Treasurer and Director
Alexion Pharmaceuticals, Inc.
$1.1M
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$722.2K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGENICS PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.